Table 3.
Incidence Rate of Liver-related Events During Follow-up
| Event |
Noncirrhotic (n = 795) |
Occult Cirrhosis (n = 29) |
Overt Cirrhosis (n = 117) |
Noncirrhotic Portal Hypertension (n = 151) | ||||
|---|---|---|---|---|---|---|---|---|
| Cases | Incidence rate (95% CI) |
Cases | Incidence rate (95% CI) |
Cases | Incidence rate (95% CI) |
Cases | Incidence rate (95% CI) |
|
| Any liver event | 5 | 3.4 (1.2–7.3) | 2 | 34.0 (6.0–104.0) | 8 | 37.0 (17.0–69.1) | 4 | 12.7 (3.94–29.5) |
| Ascites | 1 | 0.68 (.04–2.97) | 2 | 33.34 (5.54–102.89) | 5 | 21.48 (7.7–46.16) | 3 | 9.51 (2.37–24.66) |
| Varices with bleeding or banding | 2 | 1.35 (.22–4.16) | 0 | … | 0 | … | 1 | 3.08 (.18–13.55) |
| Spontaneous bacterial peritonitis | 1 | 0.67 (.04–2.96) | 0 | … | 1 | 3.83 (.22–16.85) | 0 | … |
| Hepatic encephalopathy | 0 | … | 0 | … | 3 | 11.56 (2.87–29.97) | 0 | … |
| Hepatorenal syndrome | 0 | … | 0 | … | 1 | 3.71 (.21–16.32) | 0 | … |
| HCC | 1 | 0.67 (.04–2.96) | 1 | 15.49 (.88–68.13) | 3 | 11.61 (2.89–30.08) | 1 | 3.08 (.18–13.55) |
| ESLD-related death | 0 | … | 1 | 15.33 (.87–67.44) | 1 | 3.71 (.21–16.31) | 0 | … |
Incidence rates are presented as 1000 person-years.
Abbreviations: CI, confidence interval; ESLD, end-stage liver disease; HCC, hepatocellular carcinoma.